WELP.DE vs. 2B70.DE
WELP.DE (HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF) and 2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) are both Health & Biotech Equities funds - WELP.DE tracks the MSCI World/Energy NR USD while 2B70.DE tracks the Nasdaq Biotechnology. Both are passively managed. Over the past 3 years, WELP.DE returned 12.49%/yr vs 14.71%/yr for 2B70.DE. At a 0.14 correlation, their price movements are largely independent. WELP.DE charges 0.59%/yr vs 0.35%/yr for 2B70.DE.
Performance
WELP.DE vs. 2B70.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WELP.DE achieves a 25.35% return, which is significantly higher than 2B70.DE's 14.41% return.
WELP.DE
- 1D
- 0.00%
- 1M
- -7.19%
- YTD
- 25.35%
- 6M
- 26.72%
- 1Y
- 34.31%
- 3Y*
- 12.49%
- 5Y*
- —
- 10Y*
- —
2B70.DE
- 1D
- 0.86%
- 1M
- 10.24%
- YTD
- 14.41%
- 6M
- 14.41%
- 1Y
- 54.92%
- 3Y*
- 14.71%
- 5Y*
- 6.01%
- 10Y*
- —
WELP.DE vs. 2B70.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
WELP.DE HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF | 25.35% | -1.54% | 7.90% | 0.25% | 5.34% |
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 14.41% | 18.57% | 4.69% | 2.49% | 2.00% |
Correlation
The correlation between WELP.DE and 2B70.DE is -0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Sep 20, 2022 | 0.14 |
The correlation between WELP.DE and 2B70.DE shifts across timeframes, from -0.08 (1 year) to 0.14 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WELP.DE vs. 2B70.DE — Risk / Return Rank
WELP.DE
2B70.DE
WELP.DE vs. 2B70.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELP.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| WELP.DE | 2B70.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.03 | ||
| Sortino ratioReturn per unit of downside risk | -1.47 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.45 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 2.80 | 8.71 | -5.91 |
| Martin ratioReturn relative to average drawdown | 8.57 | 25.37 | -16.80 |
Loading charts...
Drawdowns
WELP.DE vs. 2B70.DE - Drawdown Comparison
The maximum WELP.DE drawdown since its inception was -23.55%, smaller than the maximum 2B70.DE drawdown of -30.92%. Use the drawdown chart below to compare losses from any high point for WELP.DE and 2B70.DE.
Loading charts...
Drawdown Indicators
| WELP.DE | 2B70.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -23.55% | -30.92% | +7.37% |
Max Drawdown (1Y)Largest decline over 1 year | -12.22% | -6.28% | -5.94% |
Max Drawdown (3Y)Largest decline over 3 years | -23.55% | -29.42% | +5.87% |
Max Drawdown (5Y)Largest decline over 5 years | — | -30.92% | — |
Current DrawdownCurrent decline from peak | -11.07% | 0.00% | -11.07% |
Average DrawdownAverage peak-to-trough decline | -7.79% | -11.75% | +3.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.99% | 2.16% | +1.83% |
Volatility
WELP.DE vs. 2B70.DE - Volatility Comparison
HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELP.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) have volatilities of 6.59% and 6.66%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WELP.DE | 2B70.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.59% | 6.66% | -0.07% |
Volatility (6M)Calculated over the trailing 6-month period | 16.90% | 15.00% | +1.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.54% | 19.69% | -0.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.07% | 20.49% | -0.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.07% | 22.35% | -2.28% |
WELP.DE vs. 2B70.DE - Expense Ratio Comparison
WELP.DE has a 0.59% expense ratio, which is higher than 2B70.DE's 0.35% expense ratio.
Dividends
WELP.DE vs. 2B70.DE - Dividend Comparison
WELP.DE's dividend yield for the trailing twelve months is around 3.05%, while 2B70.DE has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% |
WELP.DE HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF | 3.05% | 3.78% | 3.64% | 0.79% |
Frequently Asked Questions
WELP.DE and 2B70.DE have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, 2B70.DE is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
2B70.DE is cheaper with a 0.35% expense ratio, compared with 0.59% for WELP.DE.
WELP.DE tracks MSCI World/Energy NR USD, while 2B70.DE tracks Nasdaq Biotechnology. They also come from different issuers: Amundi and iShares. Their fees differ too: 0.59% for WELP.DE and 0.35% for 2B70.DE.
Find the right allocation for WELP.DE and 2B70.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer